Author name: YASHASWINI N

World Stomach Cancer Awareness Month November- 2026 Stomach cancer begins in the cells lining the mucosal (innermost) layer of the stomach wall and spreads outward through its five tissue layers as it grows It typically develops from precancerous changes in the stomach lining that progress slowly over several years Stomach Cancer Types of Stomach Cancer Risk Factors H. pylori Infection Odds Ratio (OR): 3.0 – 6.0 1. Adenocarcinoma The most common form, arising from mucus-producing cells of the stomach lining 2. Gastrointestinal Stromal Tumor (GIST) A rare type (arising in specialized nerve-like cells (interstitial cells of Cajal) within the stomach wall Genetics & Family History Odds Ratio (OR): ~2.0 Global Prevalence Smoking & Tobacco Use Odds Ratio (OR): -1.3 Over 1M cases annually worldwide High Sodium & Processed Diet Odds Ratio (OR): ~1.2 6th most common cancer worldwide 5th most common cause of cancer deaths worldwide 15.7 - 36.9 5.8 ~ 6.9 2.4 ~ 5.6 6.9 ~ 9.4 9.4 ~ 15.7 SEER Stages Localized Regional Distant 5- Year Survival Rate: 37% The cancer has spread outside the stomach to nearby structures or lymph nodes 5- Year Survival Rate: 77% There is no sign that the cancer has spread outside of the stomach 5- Year Survival Rate: 8% The cancer has spread to distant parts of the body, such as the liver Note: These numbers are based on people who were diagnosed and treated at least 5 years earlier Diagnosis Current Treatment Category Tests / Procedures Endoscopy & Biopsy Upper Endoscopy Tissue Biopsy Biomarker & Molecular Testing HER2 Testing PD-L1 Expression MSI / dMMR Testing Imaging Tests Upper Gastrointestinal Series CT Scan Endoscopic Ultrasound (EUS) PET Scan MRI Surgery Endoscopic resection Subtotal gastrectomy Total gastrectomy Immunotherapy PD-1 Inhibitors Radiation Therapy Targeted Therapy HER2 protein VEGF receptor CLDN18.2 NTRK genes Chemotherapy Note: This report is generated based on publicly available data © Vyuhpharma®, All Rights Reserved

Stomach Cancer Awareness Month: Advancing Innovation in Gastric Oncology 🎗️🔬During Stomach Cancer Awareness Month (November), we join global healthcare leaders, researchers, and oncology advocates in driving awareness for gastric cancer—the fifth most commonly diagnosed cancer and a leading cause of cancer mortality worldwide.

Stomach Cancer Awareness Month: Advancing Innovation in Gastric Oncology 🎗️🔬During Stomach Cancer Awareness Month (November), we join global healthcare leaders, researchers, and oncology advocates in driving awareness for gastric cancer—the fifth most commonly diagnosed cancer and a leading cause of cancer mortality worldwide. Read More »

WORLD PAIN DAY 2026 Understanding Diagnosing Treating Improving Lives According to IASP 2020, Acute Pain is “an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage” Last from few seconds to 3 months PAIN PATHOPHYSIOLOGY PAIN MECHANISM Transduction Transmission Nociception Modulation Perception Mixed Nociceptive Neuropathic Nociplastic Nociceptor activation by harmful stimuli Involve more than one mechanism Caused by somatosensory system damage Altered pain processing Nociceptor activation Converts stimuli into signals Signals are centrally modulated Brain interprets pain Signals reach the brain Pain is a global health challenge ACUTE PAIN: KEY INSIGHTS ~806,000 Opioid overdose deaths, 1999-2023 ~80M people experiences acute pain annually in US 80% of ~100M US surgical patients suffer postoperative pain Pain causes >70% of ED visits; acute headaches account for 2.1M RISK FACTORS DIAGNOSTIC SCALE Blunt Trauma Numeric Rating Scale Rates pain intensity from 0 to 10 0 1 2 3 4 5 6 7 8 9 10 Surgery No pain Worst possible pain Patient selects number (0-10) to represent their pain intensity at that moment Dental Procedures Visual Analogue Scale Patient marks the line to indicate pain intensity Pulled or strained muscle 10 cm line measuring pain intensity 10 0 1 2 3 4 5 6 7 8 9 Burns SIGNS & SYMPTOMS Tingling (pinprick sensation) Throbbing ( pulsing pain) Numbness (loss of sensation) Burning (heat sensation) Stabbing pain (piercing pain) Sharp pain (sudden severe pain) NON-PHARMACOLOGICAL MANAGEMENT DIAGNOSIS of ACUTE PAIN Blood Tests CT Scan X-ray Physical Therapy (mobility & strength) Heat/Ice (🠇 infla mmation) Exercise (maintains function) Rest (🠕 healing) Stress reduction (relaxation technique) Bioelectric Therapy (nerve stimulation) Dye injection study MRI Ultrasounds NaV1.8 inhibitor PHARMACOLOGICAL MANAGEMENT NOVEL NON-OPIOID PAIN RELIEF FDA Approved Jan 30, 2025 Acetaminophen NSAIDs ☑ Blocks pain signaling before it reaches the brain ☑ First in class non-opioid sodium channel blocker for moderate- to-severe acute pain COX inhibition (centrally) Analgesic & antipyretic COX inhibition (centrally & peripherally) Anti-inflammatory ☑ Not expressed in brain ☑ Targets NaV1.8 in peripheral nociceptors First Dose From Second Dose Dosing & Administration ☑ Swallow whole; do not crush Muscle Relaxants Opioids Two 50 mg tablets One 50 mg tablet μ- receptor agonist Modulate pain pathways 🠇 muscle spasm 🠇 pain 🠕 mobility 12 hrs Adverse effects of NSAIDS: GI Bleeding Adverse effects of Opioids: Respiratory depression Less Pain Better Function Improved Quality of Life Vyuhpharma® All Rights Reserved Note: This report is generated based on publicly available data

World Day Against Pain: Redefining the Future of Pain Management 🩺💡On World Day Against Pain, launched by the World Health Organization (WHO) and the International Association for the Study of Pain (IASP), we reflect on one of the most fundamental truths: Pain management is a critical component of human health.

World Day Against Pain: Redefining the Future of Pain Management 🩺💡On World Day Against Pain, launched by the World Health Organization (WHO) and the International Association for the Study of Pain (IASP), we reflect on one of the most fundamental truths: Pain management is a critical component of human health. Read More »

Connect with us

Please fill in the information below, and we'll get back to you.